nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.055	0.055	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0538	0.0538	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0469	0.0469	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0459	0.0459	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0455	0.0455	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0445	0.0445	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0424	0.0424	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0415	0.0415	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0394	0.0394	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0386	0.0386	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0383	0.0383	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0374	0.0374	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0357	0.0357	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0349	0.0349	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0297	0.0297	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0291	0.0291	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.025	0.025	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.0247	0.0247	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0244	0.0244	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0204	0.0204	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0198	0.0198	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0129	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00905	0.00905	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00885	0.00885	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00879	0.00879	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00859	0.00859	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00818	0.00818	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00801	0.00801	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00775	0.00775	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00759	0.00759	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00753	0.00753	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00736	0.00736	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00701	0.00701	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00686	0.00686	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0059	0.0059	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00578	0.00578	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00573	0.00573	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00573	0.00573	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00561	0.00561	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00561	0.00561	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00534	0.00534	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00522	0.00522	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00491	0.00491	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0048	0.0048	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00374	0.00374	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00366	0.00366	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00334	0.00334	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00326	0.00326	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00324	0.00324	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00317	0.00317	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00303	0.00303	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00302	0.00302	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00296	0.00296	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00295	0.00295	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00294	0.00294	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00288	0.00288	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00274	0.00274	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00268	0.00268	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00211	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00207	0.00207	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00192	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00188	0.00188	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00179	0.00179	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00175	0.00175	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00174	0.00174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0017	0.0017	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00162	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00158	0.00158	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00113	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00111	CbGpPWpGaD
